Inducting and Stabilizing Opioid-dependent Pregnant Women on Methadone or Buprenorphine: Current Research and Future Treatment Implications

 







Tuesday, December 14, 2010

Inducting and Stabilizing Opioid-dependent Pregnant Women on Methadone or Buprenorphine: Current Research and Future Treatment Implications

Hendree E. Jones, Ph.D.
Professor, Department of Psychiatry and Behavioral Sciences
Joint Appointment in Obstetrics and Gynecology
Johns Hopkins School of Medicine 

Dr. Jones will discuss her work from the recently completed eight-site, multi-center trial Maternal Opioid Treatment: Human Experimental Research (MOTHER) that compared the fetal, neonatal and maternal safety and efficacy of methadone and buprenorphine medications for pregnant opioid dependent women. She will discuss induction and stabilization of pregnant women on these medications, the risks and benefits for mother, fetus and neonate as well as discuss the latest evidence based guidance for managing acute pain, breastfeeding and neonatal abstinence syndrome in the opioid-exposed neonate.

Supplemental Materials:  

Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
N Engl J Med 2010; 363:2320-2331 December 9, 2010 

PCSS-B Webinar References December 14, 2010

To view the NAS Tool referred to in Dr. Jones' presentation click here.

Webinar Supplemental Q&A:  December 14, 2010

We value your feedback and would like to hear from you.  Please email us at pcssb@psych.org to provide your comments or suggestions for future webinar topics.